Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 362

1.

The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.

Kietselaer BL, Hofstra L, Dumont EA, Reutelingsperger CP, Heidendal GA.

Q J Nucl Med. 2003 Dec;47(4):349-61. Review.

2.

Imaging cell death in vivo.

Blankenberg F, Mari C, Strauss HW.

Q J Nucl Med. 2003 Dec;47(4):337-48. Review.

3.
4.
5.

Non-oncologic applications of radiolabeled peptides in nuclear medicine.

Knight LC.

Q J Nucl Med. 2003 Dec;47(4):279-91. Review.

6.

The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis.

Dalm VA, van Hagen PM, Krenning EP.

Q J Nucl Med. 2003 Dec;47(4):270-8. Review.

7.

The developing role of peptide radiopharmaceuticals in the study of chronic inflammation: new techniques for novel therapeutic options.

Chianelli M, Parisella MG, D'Alessandria C, Corsetti F, Scopinaro F, Signore A.

Q J Nucl Med. 2003 Dec;47(4):256-69. Review.

8.

Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.

van Eerd JE, Boerman OC, Corstens FH, Oyen WJ.

Q J Nucl Med. 2003 Dec;47(4):246-55. Review.

9.

99mTc-antimicrobial peptides: promising candidates for infection imaging.

Lupetti A, Pauwels EK, Nibbering PH, Welling MM.

Q J Nucl Med. 2003 Dec;47(4):238-45. Review.

10.

Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.

Sosabowsky J, Melendez-Alafort L, Mather S.

Q J Nucl Med. 2003 Dec;47(4):223-37. Review.

11.

Radiopharmaceuticals for targeting the angiogenesis marker alpha(v)beta(3).

McQuade P, KnIght LC.

Q J Nucl Med. 2003 Sep;47(3):209-20. Review.

12.

Imaging matrix metalloproteinase expression in tumors.

Li WP, Anderson CJ.

Q J Nucl Med. 2003 Sep;47(3):201-8. Review.

13.

Radiotracer-based strategies to image angiogenesis.

Haubner RH, Wester HJ, Weber WA, Schwaiger M.

Q J Nucl Med. 2003 Sep;47(3):189-99. Review.

14.

CT imaging of angiogenesis.

Lee TY, Purdie TG, Stewart E.

Q J Nucl Med. 2003 Sep;47(3):171-87. Review.

15.

Imaging the effects of anti-angiogenic treatments.

Vāvere AL, Lewis JS.

Q J Nucl Med. 2003 Sep;47(3):163-70. Review.

16.

Angiogenic and angiostatic factors in the molecular control of angiogenesis.

Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O.

Q J Nucl Med. 2003 Sep;47(3):149-61. Review.

17.
18.
19.

The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection.

Spanu A, Tanda F, Dettori G, Manca A, Chessa F, Porcu A, Falchi A, Nuvoli S, Madeddu G.

Q J Nucl Med. 2003 Jun;47(2):116-28.

20.

Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?

Fuster D, Maurel J, Muxí A, Setoain X, Ayuso C, Martín F, Ortega ML, Fuertes S, Pons F.

Q J Nucl Med. 2003 Jun;47(2):109-15.

Supplemental Content

Loading ...
Support Center